These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 6223827)

  • 41. Differential selectivities of RU 24969 and 8-OH-DPAT for the purported 5-HT1A and 5-HT1B binding sites. Correlation between 5-HT1A affinity and hypotensive activity.
    Doods HN; Kalkman HO; De Jonge A; Thoolen MJ; Wilffert B; Timmermans PB; Van Zwieten PA
    Eur J Pharmacol; 1985 Jun; 112(3):363-70. PubMed ID: 3160596
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CGS 18102A, a benzopyranopyridine anxiolytic with 5-HT1 agonist and 5-HT2 antagonist properties.
    Sills MA; Bennett DA; Lovell RA; Liebman JM; Wood PL; Glaeser BS; Williams M; Hutchison AJ
    Prog Clin Biol Res; 1990; 361():469-75. PubMed ID: 1981265
    [No Abstract]   [Full Text] [Related]  

  • 43. Similar effects of treatment with desipramine and electroconvulsive shock on 5-hydroxytryptamine1A receptors in rat brain.
    Pandey SC; Isaac L; Davis JM; Pandey GN
    Eur J Pharmacol; 1991 Sep; 202(2):221-5. PubMed ID: 1839385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype.
    Verge D; Daval G; Patey A; Gozlan H; el Mestikawy S; Hamon M
    Eur J Pharmacol; 1985 Jul; 113(3):463-4. PubMed ID: 2931289
    [No Abstract]   [Full Text] [Related]  

  • 45. Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI.
    Arnt J; Hyttel J
    Eur J Pharmacol; 1989 Feb; 161(1):45-51. PubMed ID: 2524390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of variation over 24-hours in response to stimulation of 5-HT1 receptors in the mouse brain.
    Moser PC; Redfern PH
    Chronobiol Int; 1985; 2(4):235-8. PubMed ID: 2966688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors.
    Hutson PH; Dourish CT; Curzon G
    Eur J Pharmacol; 1986 Oct; 129(3):347-52. PubMed ID: 2430815
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 125I-Bolton-Hunter-8-methoxy-2-[N-propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies.
    Gozlan H; Ponchant M; Daval G; Verge D; Menard F; Vanhove A; Beaucourt JP; Hamon M
    J Pharmacol Exp Ther; 1988 Feb; 244(2):751-9. PubMed ID: 2964524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urapidil analogues are potent ligands of the 5-HT1A receptor.
    Gross G; Schüttler K; Xin X; Hanft G
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S8-16. PubMed ID: 1702491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Yamada J; Sugimoto Y; Horisaka K
    Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Median raphe, but not dorsal raphe, application of the 5-HT1A agonist 8-OH-DPAT stimulates rat motor activity.
    Hillegaart V; Hjorth S
    Eur J Pharmacol; 1989 Jan; 160(2):303-7. PubMed ID: 2527161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Corticosterone response to 8-OH-DPAT after chronic administration of antidepressants.
    Akiyoshi J; Nagayama H; Tsuchiyama K; Yamada K; Miyamoto T; Ito Y; Yamauchi C; Oba A; Okada K; Kojima K
    Jpn J Psychiatry Neurol; 1991 Mar; 45(1):141-2. PubMed ID: 1836505
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacological characterization of release-regulating serotonin autoreceptors in rat cerebellum.
    Bonanno G; Maura G; Raiteri M
    Eur J Pharmacol; 1986 Jul; 126(3):317-21. PubMed ID: 2944750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebrovascular and functional consequences of 5-HT1A receptor activation.
    McBean DE; Sharkey J; Ritchie IM; Kelly PA
    Brain Res; 1991 Jul; 555(1):159-63. PubMed ID: 1834308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of a beta-adrenergic agonist on behaviors mediated by 5-HT1A and 5-HT1B receptors.
    Frances H; Simon P
    Biol Psychiatry; 1986 Sep; 21(11):1075-7. PubMed ID: 2943324
    [No Abstract]   [Full Text] [Related]  

  • 56. NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Glennon RA; Naiman NA; Pierson ME; Titeler M; Lyon RA; Weisberg E
    Eur J Pharmacol; 1988 Sep; 154(3):339-41. PubMed ID: 2976673
    [No Abstract]   [Full Text] [Related]  

  • 57. [125I-BH-8-MeO-N-PAT, a new ligand for the study of 5-HT1A receptors in the central nervous system].
    Ponchant M; Beaucourt JP; Vanhove A; Daval G; Vergé D; Hamon M; Gozlan H
    C R Acad Sci III; 1988; 306(4):147-52. PubMed ID: 2965963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determination of the molecular size of the 5-HT3 receptor binding site by radiation inactivation.
    Gozlan H; Schechter LE; Bolanos F; Emerit MB; Miquel MC; Nielsen M; Hamon M
    Eur J Pharmacol; 1989 Dec; 172(6):497-500. PubMed ID: 2533081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 8-Hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicits eating in free-feeding rats by acting on central serotonin neurons.
    Bendotti C; Samanin R
    Eur J Pharmacol; 1986 Feb; 121(1):147-50. PubMed ID: 2937644
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 5-HT1A-agonistic properties of naftopidil, a novel antihypertensive drug.
    Borbe HO; Metzenauer P; Szelenyi I
    Eur J Pharmacol; 1991 Nov; 205(1):105-7. PubMed ID: 1839829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.